Insomnia Therapeutics Drugs Market Size, Share, Growth, and Industry Analysis, By Type (Benzodiazepines,Nonbenzodiazepines,Antidepressants,Orexin Antagonists,Melatonin Antagonists,Others), By Application (Prescription,Over-the-Counter (OTC)), Regional Insights and Forecast to 2035

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Benzodiazepines
1.2.3 Nonbenzodiazepines
1.2.4 Antidepressants
1.2.5 Orexin Antagonists
1.2.6 Melatonin Antagonists
1.2.7 Others
1.3 Market by Application
1.3.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Prescription
1.3.3 Over-the-Counter (OTC)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Insomnia Therapeutics Drugs Market Perspective (2018-2029)
2.2 Global Insomnia Therapeutics Drugs Growth Trends by Region
2.2.1 Insomnia Therapeutics Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Insomnia Therapeutics Drugs Historic Market Size by Region (2018-2023)
2.2.3 Insomnia Therapeutics Drugs Forecasted Market Size by Region (2024-2029)
2.3 Insomnia Therapeutics Drugs Market Dynamics
2.3.1 Insomnia Therapeutics Drugs Industry Trends
2.3.2 Insomnia Therapeutics Drugs Market Drivers
2.3.3 Insomnia Therapeutics Drugs Market Challenges
2.3.4 Insomnia Therapeutics Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Insomnia Therapeutics Drugs by Players
3.1.1 Global Insomnia Therapeutics Drugs Revenue by Players (2018-2023)
3.1.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Insomnia Therapeutics Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Insomnia Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Insomnia Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapeutics Drugs Revenue in 2022
3.5 Global Key Players of Insomnia Therapeutics Drugs Head office and Area Served
3.6 Global Key Players of Insomnia Therapeutics Drugs, Product and Application
3.7 Global Key Players of Insomnia Therapeutics Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Insomnia Therapeutics Drugs Breakdown Data by Type
4.1 Global Insomnia Therapeutics Drugs Historic Market Size by Type (2018-2023)
4.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2024-2029)
5 Insomnia Therapeutics Drugs Breakdown Data by Application
5.1 Global Insomnia Therapeutics Drugs Historic Market Size by Application (2018-2023)
5.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Insomnia Therapeutics Drugs Market Size (2018-2029)
6.2 North America Insomnia Therapeutics Drugs Market Size by Type
6.2.1 North America Insomnia Therapeutics Drugs Market Size by Type (2018-2023)
6.2.2 North America Insomnia Therapeutics Drugs Market Size by Type (2024-2029)
6.2.3 North America Insomnia Therapeutics Drugs Market Share by Type (2018-2029)
6.3 North America Insomnia Therapeutics Drugs Market Size by Application
6.3.1 North America Insomnia Therapeutics Drugs Market Size by Application (2018-2023)
6.3.2 North America Insomnia Therapeutics Drugs Market Size by Application (2024-2029)
6.3.3 North America Insomnia Therapeutics Drugs Market Share by Application (2018-2029)
6.4 North America Insomnia Therapeutics Drugs Market Size by Country
6.4.1 North America Insomnia Therapeutics Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Insomnia Therapeutics Drugs Market Size by Country (2018-2023)
6.4.3 North America Insomnia Therapeutics Drugs Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Insomnia Therapeutics Drugs Market Size (2018-2029)
7.2 Europe Insomnia Therapeutics Drugs Market Size by Type
7.2.1 Europe Insomnia Therapeutics Drugs Market Size by Type (2018-2023)
7.2.2 Europe Insomnia Therapeutics Drugs Market Size by Type (2024-2029)
7.2.3 Europe Insomnia Therapeutics Drugs Market Share by Type (2018-2029)
7.3 Europe Insomnia Therapeutics Drugs Market Size by Application
7.3.1 Europe Insomnia Therapeutics Drugs Market Size by Application (2018-2023)
7.3.2 Europe Insomnia Therapeutics Drugs Market Size by Application (2024-2029)
7.3.3 Europe Insomnia Therapeutics Drugs Market Share by Application (2018-2029)
7.4 Europe Insomnia Therapeutics Drugs Market Size by Country
7.4.1 Europe Insomnia Therapeutics Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Insomnia Therapeutics Drugs Market Size by Country (2018-2023)
7.4.3 Europe Insomnia Therapeutics Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Insomnia Therapeutics Drugs Market Size (2018-2029)
8.2 China Insomnia Therapeutics Drugs Market Size by Type
8.2.1 China Insomnia Therapeutics Drugs Market Size by Type (2018-2023)
8.2.2 China Insomnia Therapeutics Drugs Market Size by Type (2024-2029)
8.2.3 China Insomnia Therapeutics Drugs Market Share by Type (2018-2029)
8.3 China Insomnia Therapeutics Drugs Market Size by Application
8.3.1 China Insomnia Therapeutics Drugs Market Size by Application (2018-2023)
8.3.2 China Insomnia Therapeutics Drugs Market Size by Application (2024-2029)
8.3.3 China Insomnia Therapeutics Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Insomnia Therapeutics Drugs Market Size (2018-2029)
9.2 Asia Insomnia Therapeutics Drugs Market Size by Type
9.2.1 Asia Insomnia Therapeutics Drugs Market Size by Type (2018-2023)
9.2.2 Asia Insomnia Therapeutics Drugs Market Size by Type (2024-2029)
9.2.3 Asia Insomnia Therapeutics Drugs Market Share by Type (2018-2029)
9.3 Asia Insomnia Therapeutics Drugs Market Size by Application
9.3.1 Asia Insomnia Therapeutics Drugs Market Size by Application (2018-2023)
9.3.2 Asia Insomnia Therapeutics Drugs Market Size by Application (2024-2029)
9.3.3 Asia Insomnia Therapeutics Drugs Market Share by Application (2018-2029)
9.4 Asia Insomnia Therapeutics Drugs Market Size by Region
9.4.1 Asia Insomnia Therapeutics Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Insomnia Therapeutics Drugs Market Size by Region (2018-2023)
9.4.3 Asia Insomnia Therapeutics Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Insomnia Therapeutics Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Insomnia Therapeutics Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Insomnia Therapeutics Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Insomnia Therapeutics Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Insomnia Therapeutics Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Insomnia Therapeutics Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Insomnia Therapeutics Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Insomnia Therapeutics Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Insomnia Therapeutics Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Insomnia Therapeutics Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Insomnia Therapeutics Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Insomnia Therapeutics Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Insomnia Therapeutics Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Takeda Pharmaceutical Company Ltd.
11.1.1 Takeda Pharmaceutical Company Ltd. Company Details
11.1.2 Takeda Pharmaceutical Company Ltd. Business Overview
11.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Introduction
11.1.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2018-2023)
11.1.5 Takeda Pharmaceutical Company Ltd. Recent Developments
11.2 Vanda Pharmaceuticals
11.2.1 Vanda Pharmaceuticals Company Details
11.2.2 Vanda Pharmaceuticals Business Overview
11.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Introduction
11.2.4 Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2018-2023)
11.2.5 Vanda Pharmaceuticals Recent Developments
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Company Details
11.3.2 Merck & Co., Inc. Business Overview
11.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Introduction
11.3.4 Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2018-2023)
11.3.5 Merck & Co., Inc. Recent Developments
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Details
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Introduction
11.4.4 Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2018-2023)
11.4.5 Pfizer Inc. Recent Developments
11.5 Teva Pharmaceutical Industries Ltd.
11.5.1 Teva Pharmaceutical Industries Ltd. Company Details
11.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Introduction
11.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2018-2023)
11.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.6 Mylan N.V.
11.6.1 Mylan N.V. Company Details
11.6.2 Mylan N.V. Business Overview
11.6.3 Mylan N.V. Insomnia Therapeutics Drugs Introduction
11.6.4 Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2018-2023)
11.6.5 Mylan N.V. Recent Developments
11.7 Sumitomo Dainippon Pharma Co., Ltd
11.7.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
11.7.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
11.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Introduction
11.7.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2018-2023)
11.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Insomnia Therapeutics Drugs Introduction
11.8.4 Sanofi Revenue in Insomnia Therapeutics Drugs Business (2018-2023)
11.8.5 Sanofi Recent Developments
11.9 Paratek Pharmaceuticals Inc.
11.9.1 Paratek Pharmaceuticals Inc. Company Details
11.9.2 Paratek Pharmaceuticals Inc. Business Overview
11.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Introduction
11.9.4 Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2018-2023)
11.9.5 Paratek Pharmaceuticals Inc. Recent Developments
11.10 Ebb Therapeutics
11.10.1 Ebb Therapeutics Company Details
11.10.2 Ebb Therapeutics Business Overview
11.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Introduction
11.10.4 Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2018-2023)
11.10.5 Ebb Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details